Kevin Merritt

Sandler Capital's core investment strategy is long/short equity which aims to achieve capital appreciation across shifting economic and market environments by focusing on secular growth businesses (long) and secularly challenged businesses (short). The firm also manages a long/short credit strategy which aims to achieve capital appreciation as well as return from interest and dividend income. This strategy focuses on corporate credit opportunities and encompasses both long and short investments across the capital structure of companies. The firm combines a top-down macroeconomic view with bottom-up research and analysis.

S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies.

Provides financial services

Citadel Advisors employs, for the benefit of the funds, proprietary investment strategies based upon fundamental research as well as on quantitative analysis. The firm invests in the global public equity, fixed-income, credit and options markets.

Functions as a College/University

Functions as a College/University

Plural Investments manages a multi-strategy hedge fund. The firm tends to invest in the stocks of companies in the process industries, producer manufacturing and healthcare services sectors. Plural Investments invests across all market-caps, with emphasis on the stocks of mid-cap and large-cap companies. Most of their investments are in US companies, but they also invest in Europe and Asia. Plural Investments maintains a high turnover rate

LGS Foundation, Inc. is a nonprofit organization dedicated to supporting individuals and families affected by Lennox-Gastaut Syndrome (LGS), a rare, severe, and complex form of epilepsy that typically begins in early childhood and leads to lifelong disability. The private company is based in San Diego, CA. The foundation serves as a convener of patients, families, clinicians, and researchers, providing education, resources, and community support to improve quality of life and advance care. It emphasizes a collaborative, patient-family-centered approach to accelerate research and treatment development through initiatives such as research grants and programs, maintains a research agenda focusing on disease biology, biomarkers, mortality, quality of life, and disease-modifying therapies, and promotes open data sharing and clinical trial participation. Key programs include community-driven advocacy efforts, conferences to advance clinical research and care, awareness and fundraising events, and extensive support services for patients, caregivers, siblings, and bereaved families. The company was founded in 2008 by Christina SanInocencio.